Beijing Jiuhui Biotechnology Co., Ltd. announced it has received an invention patent certificate from the China National Intellectual Property Administration. The patent is for the use of a mutant 6-phosphogluconate dehydrogenase in preparing detection reagents. This patent is expected to enhance the company's core competitiveness and foster continuous innovation.
Summary generated by AI · Always verify with source document
Securities Code: 300406 Bond Code: 123150 Securities Abbreviation: Jiuhui Biotechnology Bond Abbreviation: Jiuhui Convertible Bond Announcement No.: 2026-060
Beijing Jiuhui Biotechnology Co., Ltd.
Announcement on Company Obtaining Invention Patent Certificates
The Company and all members of the Board of Directors guarantee the authenticity, accuracy, and completeness of the announcement content, and that there are no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.